1. Home
  2. OPK vs MAX Comparison

OPK vs MAX Comparison

Compare OPK & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • MAX
  • Stock Information
  • Founded
  • OPK 2007
  • MAX 2014
  • Country
  • OPK United States
  • MAX United States
  • Employees
  • OPK N/A
  • MAX N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • MAX Industrial Machinery/Components
  • Sector
  • OPK Health Care
  • MAX Industrials
  • Exchange
  • OPK Nasdaq
  • MAX Nasdaq
  • Market Cap
  • OPK 1.0B
  • MAX 551.1M
  • IPO Year
  • OPK 1995
  • MAX 2020
  • Fundamental
  • Price
  • OPK $1.39
  • MAX $13.14
  • Analyst Decision
  • OPK Buy
  • MAX Strong Buy
  • Analyst Count
  • OPK 4
  • MAX 6
  • Target Price
  • OPK $2.75
  • MAX $18.25
  • AVG Volume (30 Days)
  • OPK 2.0M
  • MAX 650.3K
  • Earning Date
  • OPK 11-06-2025
  • MAX 10-29-2025
  • Dividend Yield
  • OPK N/A
  • MAX N/A
  • EPS Growth
  • OPK N/A
  • MAX N/A
  • EPS
  • OPK N/A
  • MAX N/A
  • Revenue
  • OPK $664,029,000.00
  • MAX $1,075,712,000.00
  • Revenue This Year
  • OPK N/A
  • MAX $28.71
  • Revenue Next Year
  • OPK $0.84
  • MAX $9.61
  • P/E Ratio
  • OPK N/A
  • MAX N/A
  • Revenue Growth
  • OPK N/A
  • MAX 116.58
  • 52 Week Low
  • OPK $1.11
  • MAX $7.33
  • 52 Week High
  • OPK $2.04
  • MAX $20.91
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • MAX 69.75
  • Support Level
  • OPK $1.34
  • MAX $12.56
  • Resistance Level
  • OPK $1.44
  • MAX $13.28
  • Average True Range (ATR)
  • OPK 0.04
  • MAX 0.56
  • MACD
  • OPK -0.00
  • MAX 0.15
  • Stochastic Oscillator
  • OPK 50.00
  • MAX 88.99

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: